Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-18T02:18:50.818Z Has data issue: false hasContentIssue false

Substance abuse disorder in patients with ADHD taking methylphenidate

Published online by Cambridge University Press:  31 July 2026

T. Gutierrez Higueras*
Affiliation:
Child and Adolescent Psyciatry, Servicio Andaluz de Salud, Jaén, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder primarily diagnosed in childhood and adolescence and typically treated with methylphenidate (MPH), a stimulant medication effective in managing the core symptoms of inattention and hyperactivity. Treatment with MPH may result in an increased risk of substance misuse and abuse related to the reward and motivational pathway. Understanding the prevalence of substance use, the main substances of abuse, and the clinical consequences in this population is critical to improving treatment strategies and minimizing adverse effects.

Objectives

To evaluate the prevalence and characteristics of substance use patterns in patients with ADHD treated with methylphenidate, as well as to identify the most commonly used drugs and analyze the associated clinical and psychosocial consequences.

Methods

A literature search was conducted in Pubmed examining substance use in patients with ADHD treated with MPH, considering the presence of concomitant psychiatric disorders (mainly substance abuse disorders) and the clinical impact of MPH abuse.

Results

The review indicates that patients with ADHD and psychiatric comorbidities, such as conduct, mood, anxiety, or personality disorders, are at increased risk for MPH misuse. The risk is increased in those with coexisting substance use disorders, with alcohol, cannabis, nicotine, and cocaine use being more common. MPH abuse can generally result in self-administered use of more than prescribed doses or unconventional routes of administration, such as inhalation. The most significant adverse effects include gastrointestinal and cardiovascular events, psychosis, and exacerbation of psychiatric symptoms.

Conclusions

Substance use and abuse are generally common in patients with ADHD, with cannabis, alcohol, and nicotine being the most commonly used drugs. Treatment with methylphenidate does not appear to substantially increase the overall risk of use, although it may be associated with isolated cases of stimulant abuse.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.